Lung transplantation (LT) for late onset of non infectious pulmonary complications (LONIPC) after haematopoietic stem cell transplantation (HSCT): Results from a French adult cohort Source: Annual Congress 2010 - New clinical and experimental insights in lung transplantation Year: 2010
Noninfectious pulmonary complications of haematopoietic stem cell transplantation Source: Eur Respir Rev, 29 (156) 190119; 10.1183/16000617.0119-2019 Year: 2020
Noninfectious lung complications after allogeneic haematopoietic stem cell transplantation Source: Eur Respir J, 51 (5) 1702617; 10.1183/13993003.02617-2017 Year: 2018
Pulmonary function in very long-term survivors after allogeneic stem cell transplantation (aSCT) Source: International Congress 2018 – New insights in testing lung and respiratory muscle functions Year: 2018
Updated prevalence and risk factors for bronchiolitis obliterans syndrome after allogeneic stem cell transplantation. Source: International Congress 2018 – The importance of the pulmonary function test in different clinical settings Year: 2018
Pulmonary mycobacterial infection in allogeneic hematopoietic stem cell transplanted (HSCT) patients: A study of 7 cases Source: Annual Congress 2011 - Clinical challenges in tuberculosis Year: 2011
Determinants of cardiorespiratory fitness in young long-term survivors of hematopoietic stem cell transplantation (HSCT) Source: International Congress 2019 – Exercise physiopathology in various respiratory diseases Year: 2019
Low incidence of pulmonary complications following nonmyeloablative stem cell transplantation Source: Eur Respir J 2004; 23: 440-445 Year: 2004
Timeline of pulmonary complications after hematopoietic stem cell transplantation in children Source: International Congress 2016 – Asthma, bronchiectasis, and the risk factors for respiratory morbidity Year: 2016
Characteristics, treatment and outcomes of nontuberculous mycobacterial pulmonary disease after allogeneic haematopoietic stem cell transplant Source: Eur Respir J, 51 (5) 1702330; 10.1183/13993003.02330-2017 Year: 2018
Utility of bronchoscopy in hematopoietic stem cell transplant (HSCT) patients with pulmonary infiltrates: A prospective study. Source: Virtual Congress 2021 – Fungi, viruses, parasites and the immunocompromised Year: 2021
Pulmonary graft-versus-host disease (GVHD) post- stem cell transplant (SCT) for haematological malignancies: Good response to treatment if diagnosed early Source: Annual Congress 2012 - Diffuse parenchymal lung disease I Year: 2012
Small airways function in allogeneic hematopoietic stem cell transplant recipients worsens over time and is correlated with change in chronic GVHD grade Source: Annual Congress 2011 - Phenotyping and monitoring of airway diseases Year: 2011
Noninfectious infiltrative lung diseases after allogeneic hematopoïetic stem cell transplantation (HSCT) Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013
Airway complications after lung transplantation: risk factors and survival Source: Virtual Congress 2020 – Clinical management of lung transplant recipients Year: 2020
Asthma and atopy after allogeneic hematopoietic stem cell transplantation in children Source: Annual Congress 2009 - Paediatric respiratory epidemiology: respiratory infections and rare diseases Year: 2009
Do pre-existing abnormalities on high resolution computerised tomography predict survival after allogeneic haematopoietic stem cell transplant (HSCT)? Source: Annual Congress 2007 - Imaging modalities in asthma, COPD and emphysema Year: 2007
Pulmonary infiltrates in hematopoietic stem cell trasplantation (HSCT) recipients. Associated pulmonary and systemic inflammatory response Source: Eur Respir J 2003; 22: Suppl. 45, 334s Year: 2003
Obliterative bronchiolitis in haematopoietic stem cell transplantation: can it be treated? Source: Eur Respir J 2005; 25: 402-405 Year: 2005
Early lung function alterations after allogeneic hematopoietic stem cell transplantation Source: Annual Congress 2010 - Mechanisms and modulation of allergic inflammation in the lung Year: 2010